NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16122810 | Elacestrant dihydrochloride | 1349723-93-8 | ≧98.0% |  |
| Elacestrant dihydrochloride, also known as RAD1901, is an orally available, selective | ||||
| 20294 | Paltusotine ( CRN-00808 ) | 2172870-89-0 | ≧98.0% | _2172870-89-0.png) |
| Paltusotine is a new class of oral, selective, nonpeptide, somatostatin receptor type | ||||
| 1811121 | DCC-2618 ( Ripretinib ) | 1442472-39-0 | >98% |  |
| Ripretinib, also known as DCC-2618, is a potent, orally active and selective KIT/PDGF | ||||
| 21252 | SM-102 | 2089251-47-6 | ≧98.0% |  |
| SM-102 is an ionizable amino lipid that has been used in combination with other lipid | ||||
| 16122847 | WWL70 | 947669-91-2 | ≧98.0% |  |
| WWL70 is selective ABHD6 inhibitor, and it has shown anti-inflammatory and neuroprote | ||||
| 21255 | 2,4-dimethoxy-6-methylnicotinonitrile | 1450662-05-1 | ≧95.0% |  |
| 2,4-dimethoxy-6-methylnicotinonitrile, is a key intermediate ofLirametostat ( CPI-120 | ||||
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot | ||||
| 20275 | GS 0573 ( PMEDAP ) | 113852-41-8 | 98% Min. |  |
| GS 0573 is an antiviral compound that has been studied for potential treatment of Fel | ||||
| 21922 | Difelikefalin HCl | 2413256-25-2 | ≧98.0% |  |
| Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is a novel and potent kappa opio | ||||
| 20263 | Giredestrant tartrate | 2407529-33-1 | ≧98.0% |  |
| Giredestrant tartrate (GDC-9545 tartrate), a non-steroidal ER ligand, is an orally ac | ||||
| 6111905 | Blarcamesine HCl | 195615-84-0 | 98% Min. |  |
| Anavex2-73 is a muscarinic/σ1 ligand. ANAVEX2-73 (0.01-3.0 mg/kg i.p.) alleviated th | ||||
| 20267 | Almonertinib | 1899921-05-1 | 98% Min. |  |
| Almonertinib is an orally available inhibitor of the epidermal growth factor receptor | ||||